Clinical trial

RONICICLIB / Placebo in Combination With Chemotherapy in Small Cell Lung Cancer

NCT02161419

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2014-07-30

PhasePHASE2

Study timeline

Study start (actual)2014-07-30Date precision: day

Registry last updated2018-06-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Small Cell Lung Carcinomaunresolved

Interventions

Roniciclib (BAY1000394)DRUG

PlaceboDRUG

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

SeoulSouth Korea2 St LouisMissouri, United States1 NashvilleTennessee, United States1 ParisFrance1 PittsburghPennsylvania, United States1 CharlestonSouth Carolina, United States1 WarsawPoland1 BudapestHungary1 MarseilleFrance1 LilleFrance1 GdanskPoland1 LiègeBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02161419 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.